| Drug Name |
Diamminedichloroplatinum |
| Drug ID |
BADD_D00643 |
| Description |
Cisplatin, cisplatinum or cis-diamminedichloroplatinum(II) (CDDP) is a platinum-based chemotherapy drug used to treat various types of cancers, including sarcomas, some carcinomas (e.g. small cell lung cancer, and ovarian cancer), lymphomas and germ cell tumors. It was the first member of its class, which now also includes carboplatin and oxaliplatin. |
| Indications and Usage |
For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer. |
| Marketing Status |
approved |
| ATC Code |
L01XA01 |
| DrugBank ID |
DB00515
|
| KEGG ID |
D00275
|
| MeSH ID |
D002945
|
| PubChem ID |
441203
|
| TTD Drug ID |
D08ZRW
|
| NDC Product Code |
16729-288; 25021-253; 0143-9505; 68554-0077; 0143-9504; 68001-283; 44567-509; 50711-0001; 44567-510; 63323-103; 0703-5747; 0703-5748; 44567-530; 60505-6277; 68083-163; 44567-511; 49452-2078; 54875-0001; 67184-0010; 68083-162; 70860-206; 49812-0009; 72659-864 |
| UNII |
Q20Q21Q62J
|
| Synonyms |
Cisplatin | cis-Diamminedichloroplatinum(II) | Platinum Diamminodichloride | Diamminodichloride, Platinum | cis-Platinum | cis Platinum | Dichlorodiammineplatinum | cis-Diamminedichloroplatinum | cis Diamminedichloroplatinum | cis-Dichlorodiammineplatinum(II) | NSC-119875 | Platino | Platinol | Biocisplatinum | Platidiam |
